S-3304

DB12149InvestigationalSmall molecule

S-3304 has been used in trials studying the treatment of Lung Cancer, Solid Tumors, Non Small Cell Lung Cancer, Stage IIIB Non Small Cell Lung Cancer, and Stage IIIA Non...

Mechanism: Pharmacologically active on Matrix metalloproteinase-9 and 72 kDa type IV collagenase
Curator reviewed
Formula / weight: C₂₄H₂₀N₂O₄S₂ · 464.55 g/mol (avg)
Code names: S-3304

Resolves to

Compound

UNIIBK459F050XCAS203640-27-1ChEMBLCHEMBL297792PubChem10718956

Structure

InChIKeyYWCLDDLVLSQGSZ-JOCHJYFZSA-NSMILESCC1=CC=C(C=C1)C#CC1=CC=C(S1)S(=O)(=O)N[C@H](CC1=CNC2=CC=CC=C12)C(O)=O

Targets

P14780MMP9P08253MMP2P03956MMP1

What you can answer from here — as of July 07, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

3Clinical trialsPhase, status and sponsor resolved per trial

5+ReferencesStructured and connected to the statements they support

Which drugs share a target with S-3304, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account